SMMT
Summit Therapeutics Inc
Price:  
15.77 
USD
Volume:  
3,309,960.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SMMT Stock Forecast & Price Target

SMMT Stock Price Forecast

The average stock forecast for Summit Therapeutics Inc (SMMT) in the next 12 months is 30.67 USD. This price target corresponds to an upside of 94.46%. The range of stock forecasts for SMMT is 12.02 - 45.15 USD. Based on the ratings of 24 analysts, the consensus recommendation for SMMT is BUY.
Target Low Average Median High
Price (USD) 12.02 30.67 32.64 45.15
Upside -23.79% 94.46% 106.98% 186.30%

Recommendation Trends

The latest consensus rating for SMMT is "BUY". This is the average recommendation of 24 analysts: 0 strong sell, 0 sell, 7 hold, 11 buy, 6 strong buy. In the previous period, 24 analysts also majorly recommmended "BUY" for SMMT.

SMMT Financial Stock Forecast

Revenue This Year
3.51M
from -M
Revenue Next Year
57.83M
1,547.64%
from 3.51M
EPS This Year
-1.22
-9.80%
from -1.35
EPS Next Year
-1.17
-4.02%
from -1.22